RT Book, Section
A1 van Berkel, Victor
A1 Cudris, Jennifer
A1 Dunlap, Neal E.
A1 Gil-Bazo, Ignacio
A1 Mandish, Steven
A1 Marino, Katy Alyse
A1 Ngo, Phuong T.
A1 Perez, Cesar A.
A1 Llerena, Jose Pinto
A1 Santos, Edgardo S.
A1 Tumen, Andrew
A1 Turquie, Moises Harari
A2 Kloecker, Goetz
A2 Arnold, Susanne M.
A2 Fraig, Mostafa M.
A2 Perez, Cesar A.
SR Print(0)
ID 1176020413
T1 Non–Small Cell Lung Cancer Treatment: Metastatic
T2 Lung Cancer: Standards of Care
YR 2021
FD 2021
PB McGraw-Hill
PP New York, NY
SN 9781260136203
LK hemonc.mhmedical.com/content.aspx?aid=1176020413
RD 2024/04/16
AB Learning  ObjectivesWhat  is  oligometastatic  non–small  cell  lung  cancer  (NSCLC)?What  clinicopathological  features  are  suggestive  of  oligometastatic  disease?How  does  the  eighth  edition  of  the  TNM  (tumor,  node,  metastasis)  staging  system  account  for  this  concept?How  can  the  clinician  determine  whether  2  foci  of  lung  cancer  represent  metastatic  disease  or  independent  primary  tumors?What  is  the  ideal  treatment  approach  and  extent  of  resection  in  this  subgroup  of  patients?